HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MK-801 inhibits the induction of immediate early genes in cerebral cortex, thalamus, and hippocampus, but not in substantia nigra following middle cerebral artery occlusion.

Abstract
Middle cerebral artery (MCA) occlusion in rats induced c-fos and junB mRNA 4h later in all ipsilateral cortex outside the MCA distribution and in many subcortical structures: medial striatum; most of thalamus including medial and lateral geniculate nuclei: substantia nigra; and hippocampus. The N-methyl-D-aspartate (NMDA) antagonist, MK-801 (4 mg/kg, i.p.) inhibited c-fos and junB mRNA induction in the cortex, striatum, thalamus, and hippocampus but not in the substantia nigra. These data show that c-fos and junB mRNA induction in cortex, striatum, thalamus, hippocampus involves the activation of NMDA receptors whereas different receptors must be implicated in the induction in substantia nigra.
AuthorsH Kinouchi, F R Sharp, P H Chan, S Mikawa, H Kamii, S Arai, T Yoshimoto
JournalNeuroscience letters (Neurosci Lett) Vol. 179 Issue 1-2 Pg. 111-4 (Sep 26 1994) ISSN: 0304-3940 [Print] Ireland
PMID7845604 (Publication Type: Journal Article)
Chemical References
  • RNA, Messenger
  • Dizocilpine Maleate
Topics
  • Animals
  • Brain Chemistry (drug effects)
  • Brain Ischemia (metabolism)
  • Cerebral Arteries (physiology)
  • Cerebral Cortex (drug effects, metabolism)
  • Dizocilpine Maleate (pharmacology)
  • Gene Expression (drug effects)
  • Genes, Immediate-Early (drug effects)
  • Genes, fos (drug effects)
  • Genes, jun (drug effects)
  • Hippocampus (drug effects, metabolism)
  • Male
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Sprague-Dawley
  • Substantia Nigra (drug effects, metabolism)
  • Thalamus (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: